Corporate Member Update: Pfizer- new FDA-approved indication for XALKORI® (crizotinib) capsules

Corporate Member Update: Pfizer- new FDA-approved indication for XALKORI® (crizotinib) capsules

XALKORI® (crizotinib)
January, 2021

Pfizer Oncology is proud to announce a new FDA-approved indication for XALKORI® (crizotinib) capsules. The following information is available for State Society review:

‐ Read the Full Prescribing Information

‐ Read the Press Release

 
 
Become a NOS Member Today!
Join Now
 

Platinum Corporate Members

Gold Corporate Members